XML 115 R83.htm IDEA: XBRL DOCUMENT
v3.10.0.1

Legal Proceedings (Details) - Gilead Litigation [Member] $ in Billions | 1 Months Ended
--- | ---
Mar. 31, 2016 USD ($) Claim Defense
Legal Proceedings [Abstract] |
Number of asserted claims | Claim | 10
Percentage of entitled past sales of sofosbuvir included in award | 4.00%
Past sales of sofosbuvir included in award | $ | $ 5
Number of additional non-jury defenses asserted | Defense | 2

X
- Definition Number of additional non-jury defenses asserted in the suit. + References No definition available. + Details
Name: | ions_LossContingenciesNumberOfAdditionalNonJuryDefensesAsserted
Namespace Prefix: | ions_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Past sales of sofosbuvir, a medication used for the treatment of hepatitis C, used in calculation of award to Merck Sharp & Dohme Corp. and the Company by the jury. + References No definition available. + Details
Name: | ions_LossContingenciesPastSalesOfMedicationIncludedInAward
Namespace Prefix: | ions_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Percentage applied to past sales of sofosbuvir, a medication used for the treatment of hepatitis C, used in the calculation of award to Merck Sharp & Dohme Corp. and the Company by the jury. + References No definition available. + Details
Name: | ions_LossContingenciesPercentageAppliedToPastSalesOfMedicationIncludedInAward
Namespace Prefix: | ions_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_LossContingencyAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of pending claims pertaining to a loss contingency. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 450 -SubTopic 20 -Section 50 -Paragraph 4 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=82911808&loc=d3e14435-108349 + Details
Name: | us-gaap_LossContingencyPendingClaimsNumber
Namespace Prefix: | us-gaap_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Details
Name: | srt_LitigationCaseAxis=ions_SuitRelatedToUSPatentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |